Septicemia from Lactobacillus rhamnosus GG, from a Probiotic Enriched Yogurt, in a Patient with Autologous Stem Cell Transplantation

Probiotics and Antimicrobial Proteins

Volumn 11, Issue 1, 2019, Pages 295-298

  Koyama, Satoshi ^a,b   Fujita, Hiroyuki ^a,c   Shimosato, Takeshi ^d   Kamijo, Aki ^e   Ishiyama, Yasufumi ^a,b   Yamamoto, Eri ^a,f   Ishii, Yoshimi ^a,f   Hattori, Yukako ^a,g   Hagihara, Maki ^a   Yamazaki, Etsuko ^a,e   Tomita, Naoto ^a,h   Nakajima, Hideaki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c Department of Urology   (Japan)

^d SHINSHU UNIVERSITY   (Japan)

^e YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^f YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^g Fujisawa City Hospital   (Japan)

^h ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lactobacillus; Leukemia; Probiotic yogurt, bacteremia; Stem cell transplantation

Indexed keywords

AMPICILLIN; BUSULFAN; CARBAPENEM DERIVATIVE; CEFEPIME; DORIPENEM; MELPHALAN; PROBIOTIC AGENT; RIBOSOME RNA; VANCOMYCIN; YOGHURT;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTERIAL STRAIN; CASE REPORT; CLINICAL ARTICLE; CLOSTRIDIUM BUTYRICUM; CONSCIOUSNESS; DIARRHEA; DRUG SUBSTITUTION; HUMAN; LACTOBACILLUS RHAMNOSUS; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHIL COUNT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SEPTIC SHOCK; SEPTICEMIA; AUTOTRANSPLANTATION; GROWTH, DEVELOPMENT AND AGING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA; MICROBIOLOGY; PHYSIOLOGY; SEPSIS;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LACTOBACILLUS RHAMNOSUS; LEUKEMIA; MALE; MIDDLE AGED; PROBIOTICS; SEPSIS; TRANSPLANTATION, AUTOLOGOUS; YOGURT;

EID: 85042065244     PISSN: 18671306     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12602-018-9399-6     Document Type: Article

References (18)

1. Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, Fondén R, Saxelin M, Collins K, Mogensen G, Birkeland SE, Mattila-Sandholm T (1998) Demonstration of safety of probiotics -- a review. Int J Food Microbiol 44:93–106
2. Wells JM (2011) Immunomodulatory mechanisms of lactobacilli. Microb Cell Factories 10(Suppl 1):S17
3. Srinivasan R, Meyer R, Padmanabhan R, Britto J (2006) Clinical safety of lactobacillus casei shirota as a probiotic in critically ill children. J Pediatr Gastroenterol Nutr 42:171–173
4. Antony SJ, Stratton CW, Dummer JS (1996) Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis 23:773–778
5. Griffiths JK, Daly JS, Dodge RA (1992) Two cases of endocarditis due to lactobacillus species: antimicrobial susceptibility, review, and discussion of therapy. Clin Infect Dis 15:250–255
6. Sussman JI, Baron EJ, Goldberg SM, Kaplan MH, Pizzarello RA (1986) Clinical manifestations and therapy of lactobacillus endocarditis: report of a case and review of the literature. Rev Infect Dis 8:771–776
7. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115:178–181
8. Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA (2013) Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol 47:437–439
9. Mehta A, Rangarajan S, Borate U (2013) A cautionary tale for probiotic use in hematopoietic SCT patients-lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT. Bone Marrow Transplant 48:461–462
10. Ward LJ, Timmins MJ (1999) Differentiation of lactobacillus casei, lactobacillus paracasei and lactobacillus rhamnosus by polymerase chain reaction. Lett Appl Microbiol 29:90–92
11. Ahlroos T, Tynkkynen S (2009) Quantitative strain-specific detection of lactobacillus rhamnosus GG in human faecal samples by real-time PCR. J Appl Microbiol 106:506–514
12. Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A (2004) Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 38:62–69
13. Fenicia L, Anniballi F, Aureli P (2007) Intestinal toxemia botulism in Italy, 1984-2005. Eur J Clin Microbiol Infect Dis 26:385–394
14. Howard FM, Flynn DM, Bradley JM, Noone P, Szawatkowski M (1977) Outbreak of necrotising enterocolitis caused by clostridium butyricum. Lancet 2:1099–1102
15. Kimura SI, Fujita H, Kato H, Hiramoto N, Hosono N, Takahashi T, Shigeno K, Hatsumi N, Minamiguchi H, Miyatake J, Handa H, Akiyama N, Kanda Y, Yoshida M, Kiyoi H, Miyazaki Y, Naoe T; Japan Adult Leukemia Study Group (JALSG). (2017) Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group. Support Care Cancer. Jun 6. 10.1007/s00520-017-3775-8
16. Gardner A, Mattiuzzi G, Faderl S, Borthakur G, Garcia-Manero G, Pierce S, Brandt M, Estey E (2008) Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol 26:5684–5688
17. Moody K, Finlay J, Mancuso C, Charlson M (2006) Feasibility and safety of a pilot randomized trial of infection rate: neutropenic diet versus standard food safety guidelines. J Pediatr Hematol Oncol 28:126–133
18. van Tiel F, Harbers MM, Terporten PH, van Boxtel RT, Kessels AG, Voss GB, Schouten HC (2007) Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety. Ann Oncol 18:1080–1084